Clik here to view.
創薬研究と医薬品開発の生産性向上を実現する総合的ソリューション「D360」の日本での販売開始について
東京およびミズーリ州セントルイス （ビジネスワイヤ）–最先端の科学技術に基づく医薬品開発および医薬品安全性コンサルティングの世界的リーダーであるサターラ（Certara®）は、創薬研究および医薬品開発におけるデータの検索、解析および視覚化を支援する総合的ソリューションである「D360」の日本における販売開始を本日発表しました。...
View ArticleClik here to view.
Certara Launches D360 in Japan to Improve Drug Discovery and Development...
TOKYO & ST. LOUIS Certara®, the leading global technology-enabled drug development and drug safety consultancy, today announced the launch in Japan of D360, its integrated solution for the...
View ArticleClik here to view.
NCKU Teams Shine at Innovation & Startups Final Competition
TAINAN, Taiwan A total of four teams from National Cheng Kung University (NCKU), southern Taiwan, won big at the competition of Innovation & Startups program initiated by the Ministry of Science...
View ArticleClik here to view.
松下的医疗保健解决方案简化了医学治疗
日本大阪 (美国商业资讯) – 2014年7月16至18日，国际现代医院展在东京国际展览中心召开，松下医疗有限公司（Panasonic Healthcare Co., Ltd.）在会上展示了该公司最新的解决方案，其主题是“为人人提供最佳医疗保健”。 在下列5个领域展示了种类广泛的解决方案：医院、诊所、居家照护、药房和医疗保健。 Newly-evolved Automatic Tablet...
View ArticleClik here to view.
Kapa Biosystems Strengthens Investment across Asia Pacific Region by...
WILMINGTON, Mass. Kapa Biosystems announced today that it has signed a new three-year exclusive distribution agreement with Nippon Genetics Co., Ltd., further extending the successful seven-year...
View ArticleClik here to view.
ReproCELL Expects Synergy and Business Benefits through the Acquisitions of...
YOKOHAMA, Japan ReproCELL (JASDAQ:4978) was established as a venture company originating from the University of Tokyo and Kyoto University and has been the pioneer in the iPS cell business,...
View ArticleClik here to view.
Evaluate Founder and CEO Receives PharmaVOICE 100 Award
LONDON & BOSTON & TOKYO Life science market intelligence company, Evaluate, Ltd., announced today that Founder and CEO, Dr. Jonathan de Pass, has been selected by PharmaVOICE magazine as one...
View ArticleClik here to view.
NanoString Technologies Receives Market Approval From the Australian...
SEATTLE NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translational research and developer of molecular diagnostic products, today announced that it has received...
View ArticleClik here to view.
Alvogen Acquires Korean Dream Pharma for US$ 187 Million
PINEBROOK, N.J. Alvogen, the international pharmaceuticals company announced today that it has acquired Dream Pharma (“Dream”) in South Korea for US$ 187 million in cash. Dream will be acquired...
View ArticleClik here to view.
Gynesonics Names Richard P. Lanigan Vice President, Global Commercialization
REDWOOD CITY, Calif. Gynesonics, Inc., a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced it has named veteran...
View ArticleClik here to view.
Baxter Opens Its First State-of-the-Art Biologics Facility in Asia, Announces...
SINGAPORE Baxter International Inc. (NYSE: BAX) today announced the formal opening of its first advanced recombinant biologic facility in Singapore, and expansion plans for a new recombinant protein...
View ArticleClik here to view.
ZRG Partners Life Sciences Hiring Index Q2 Declines Slightly but Still Near...
WEST ORANGE, N.J. ZRG Partners, Inc. announces the results of its second quarter Global Life Sciences Hiring Index. Q2 displays a slightly negative turn but the overall outlook remains positive with...
View ArticleClik here to view.
ボストン・ストラテジクス: エーザイとのライセンス契約を発表
ボストン （ビジネスワイヤ） — 米国マサチューセッツ州ボストンに本社をおく臨床ステージの総合医薬品研究開発会社Boston Strategics Corporation（BSC）は、日本のグローバル製薬会社であるエーザイ株式会社（エーザイ）と同社の抗がん剤E6201について独占的導入開発契約を締結したと発表しました。 E6201はFLT3/MEKの二重キナーゼ阻害剤で、Phase...
View ArticleClik here to view.
Terumo BCT宣布合作项目，以评估采用Quantum系统进行细胞临床生产
科罗拉多州LAKEWOOD (美国商业资讯) — Athersys, Inc.是一家致力于干细胞疗法研发的生物制药公司，该公司正在评估Terumo BCT的Quantum® Cell Expansion System能否作为Athersys的同种异源多能成体祖细胞(MAPC®)产品的制造平台。Athersys在比利时的分公司ReGenesys BVBA将担当此次评估。...
View ArticleClik here to view.
FDA Approves VELCADE® (bortezomib) Retreatment in Patients with Multiple Myeloma
CAMBRIDGE, Mass. Millennium: The Takeda Oncology Company with its parent company, Takeda Pharmaceutical Company Limited (TSE:4502), today announced that the U.S. Food and Drug Administration (FDA)...
View ArticleClik here to view.
Jinchi Biotech Ltd Held 2014 Semi-Annual Marketing Conference
ZHANGJIAJIE, China Jinchi Biotech Ltd. (JBL) 2014 Semi–Annual Marketing Conference was held in Changsha Headquarter on July 28, 2014, attended by Mr. Haibo Zhang – Chairman, Mr. Jing Cai – CEO, Ms....
View ArticleClik here to view.
Abcam Establishes New Direct Service for Australia and New Zealand
CAMBRIDGE, England Abcam plc, a global leader in the supply of innovative protein research tools, announced today it has established a direct service to Australia and New Zealand. The move signifies...
View ArticleClik here to view.
Pfizer Reports Top-line Results from Postherpetic Neuralgia and Painful...
NEW YORK Pfizer Inc. (NYSE:PFE) announced today top-line results from two placebo-controlled studies conducted in China with Lyrica® (pregabalin) in patients with postherpetic neuralgia (pain after...
View ArticleClik here to view.
Catalent证实任命两位资深医疗保健经理人为公司董事
新泽西州萨默塞特 (美国商业资讯)–Catalent, Inc. (NYSE:CTLT)是面向药品、生物制剂和消费者健康产品的药物开发解决方案和高级投药技术的全球领先者，该公司今天宣布，任命Jack Stahl和Rolf Classon为公司董事。 Jack Stahl先生于2002至2006年担任Revlon,...
View ArticleClik here to view.
Provectus Signs Memorandum of Understanding with Sinopharm-China State...
KNOXVILLE, Tenn. Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT) (http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company (“Provectus”), announced today that...
View Article